Europe needs change to drive added value

15 September 2017

European report calms common concerns

15 September 2017

2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments

12 September 2017

Biosimilar medicines are transforming treatment by enabling better access to […]

Oncology, the new era for biosimilar medicines

8 September 2017

With more than 10 years of positive experience and 700 […]

Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation

5 September 2017

A new study “Value Added Medicines: Time to Adjust the […]

País pode poupar “mais 100 milhões por ano” com genéricos

18 July 2017

Europäer zahlen zu viel für Pillen

18 July 2017

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017